Anna Gil-Sánchez

6PUBLICATIONS
29CO-AUTHORS
Gene and molecular therapyMedical infection agents (incl. prions)AutoimmunityEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 13, 2025
Profile of Cytokines Associated with SARS-CoV2 Seropositivity in Multiple Sclerosis Patients and Its Persistence over Six Months.

Agustín Sancho-Saldaña, Anna Gil-Sánchez, Bibiana Quirant-Sánchez

|Mar 13, 2025
Novel Cell Models to Study Myelin and Microglia Interactions.

Marta Santacreu-Vilaseca, Judith Moreno-Magallon, Alba Juanes-Casado

|Apr 27, 2024
Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?

Anna Gil-Sánchez, Hugo Gonzalo, Marc Canudes

|Dec 09, 2023
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.

Agustín Sancho-Saldaña, Anna Gil-Sánchez, Cristina González-Mingot

|Nov 08, 2023
Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study.

Cristina González Mingot, Sonia Santos Lasaosa, Laura Colàs Campàs

|May 14, 2022
Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies.

Agustín Sancho-Saldaña, Anna Gil Sánchez, Bibiana Quirant-Sánchez

Pageof 1

Frequent Collaborators

5 joint publications

Cristina González-Mingot

4 joint publications

Luis Brieva Ruiz

3 joint publications

Pascual Torres

2 joint publications

Bibiana Quirant-Sánchez